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Abstract. 
 
The formation of axon tracts in nervous sys-
tem histogenesis is the result of selective axon fascicula-
tion and specific growth cone guidance in embryonic 
development. One group of proteins implicated in neu-
rite outgrowth, fasciculation, and guidance is the neural 
members of the Ig superfamily (IgSF). In an attempt to 
identify and characterize new proteins of this superfam-
ily in the developing nervous system, we used a PCR-
based strategy with degenerated primers that represent 
conserved sequences around the characteristic cysteine 
residues of Ig-like domains. Using this approach, we 
identified a novel neural IgSF member, termed neu-
rotractin. This GPI-linked cell surface glycoprotein is 
composed of three Ig-like domains and belongs to the 
IgLON subgroup of neural IgSF members. It is ex-
pressed in two isoforms with apparent molecular 
masses of 50 and 37 kD, termed L-form and S-form, re-
spectively. Monoclonal antibodies were used to analyze 
its biochemical features and histological distribution. 
Neurotractin is restricted to subsets of developing com-
missural and longitudinal axon tracts in the chick cen-
tral nervous system. Recombinant neurotractin pro-
motes neurite outgrowth of telencephalic neurons and 
 
interacts with the IgSF members CEPU-1 (
 
K
 
D
 
 
 
5 
 
3 
 
3 
 
10
 
2
 
8
 
 M) and LAMP. Our data suggest that neurotractin 
participates in the regulation of neurite outgrowth in 
the developing brain.
Key words: cell adhesion • development • Ig super-
family • neurite outgrowth • nervous system
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 of the nervous system in brain embryo-
genesis is a complex and fascinating process
which is dependent on the axonal growth cone’s
ability to interpret environmental cues along the pathway
to its target region. In line with the complexity of the envi-
ronment through which axons have to navigate, multiple
 
different classes of molecular cues have been implicated
in axonal elongation and guidance (Tessier-Lavigne and
Goodman, 1996; Drescher et al., 1997).
Currently, the most diversified class of molecules that is
involved in contact-dependent regulation of neurite out-
growth and axon guidance are the neural members of the
immunoglobulin superfamily (IgSF)
 
1
 
 (Walsh and Doherty,
1997; Sonderegger, 1998; Stoeckli and Landmesser, 1998;
Van Vactor, 1998). These proteins show complex and pro-
miscuous extracellular interactions (Brümmendorf and
Rathjen, 1996) which appears to be a common feature
of contact dependent cell surface molecules implicated
in axon guidance (Drescher et al., 1997; Flanagan and
Vanderhaeghen, 1998). Recently, functional in vitro analy-
ses of neural IgSF members have been strongly supported
by intriguing in vivo observations. For instance, L1-associ-
ated hereditary disorders coincide with malformation or
 
even loss of selected axon tracts (reviewed in Kenwrick
et al., 1996; Fransen et al., 1997; Kamiguchi et al., 1998;
Brümmendorf et al., 1998), and analyses of L1-deficient
 
1.
 
 Abbreviations used in this paper:
 
 ALF, automated laser fluorescent;
IgLON, LAMP/OBCAM/neurotrimin subgroup of the IgSF; IgSF, immu-
noglobulin superfamily; LAMP, limbic system-associated membrane pro-
tein; NgCAM, neuron-glia cell adhesion molecule; NrCAM, NgCAM-
related cell adhesion molecule; OBCAM, opioid binding cell adhesion
molecule; PI-PLC, phosphatidylinositol-specific phospholipase C; RT,
room temperature.
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mice demonstrated that L1 protein plays a role in the for-
mation of the corticospinal tract (Cohen et al., 1998;
Dahme et al., 1997). Other recent examples of IgSF mem-
bers implicated in axon guidance include DCC (Deiner et al.,
1997) and neurolin (Ott et al., 1998) in the retina, OCAM
in the olfactory system (Yoshihara and Mori, 1997),
roundabout-1 at the 
 
Drosophila 
 
midline (Kidd et al.,
1998), NrCAM in the spinal cord (Stoeckli and Land-
messer, 1998), and limbic system–associated membrane
protein (LAMP) in the hippocampus (Pimenta et al.,
1995).
To examine the complex biology of neural IgSF mole-
cules further we are interested in the identification and
functional characterization of novel members of this su-
perfamily. Recently, we succeeded to clone cDNAs of
novel proteins by a systematic PCR approach, among
them CEPU-1, which is strongly expressed by cerebellar
Purkinje cells and weakly in other brain regions (Spalt-
mann and Brümmendorf, 1996). In this study, we describe
the cloning and functional characterization of a novel
member of this superfamily on subsets of commissural and
longitudinal central nervous system axon tracts, termed
neurotractin. Recombinant neurotractin promotes neurite
outgrowth of telencephalic neurons. It interacts with the
CEPU-1 protein (
 
K
 
D
 
 
 
5 
 
3 
 
3
 
 10
 
2
 
8
 
 M) and with LAMP
which both belong to the same subgroup but not with neu-
ral IgSF members of the F11 or L1 subgroup. The spa-
tiotemporal expression pattern and the functional link to
axonal elongation suggests that neurotractin plays a role in
the development of central nervous system axon tracts.
 
Materials and Methods
 
Cloning of Neurotractin cDNA
 
Sequences encoding fragments of Ig-like molecules were amplified by
PCR from embryonic day 11–13 (E11-E13) brain mRNA and subcloned
into plasmid pSKII (Stratagene) as outlined previously (Spaltmann and
Brümmendorf, 1996). One clone, termed kb14, which contained a 290-bp
insert with a novel Ig-like sequence was used to isolate clone pCMV/z14
by hybridization screening of an E16 
 
l
 
ZAP library (Plagge and Brüm-
mendorf, 1997) and in vivo excision as a pBK-CMV plasmid (Stratagene).
As clone z14 did not contain the complete coding sequence of the novel
molecule, a 5
 
9
 
-terminal EcoRI-PstI restriction fragment of 200 bp was
used as a hybridization probe to isolate further phages from a chicken spi-
nal cord cDNA library (
 
l
 
UNI-ZAP; Stratagene). Two of them, termed
clones sc3 and sc4, which contain the L-form and the S-form, respectively,
were subcloned into pSKII (Stratagene). Nucleotide sequences of z14, sc3,
and sc4 were determined on both strands by the dideoxy chain termina-
tion method using the ALF (automated laser fluorescent) DNA se-
quencer (Pharmacia). The clones differed in two amino acid positions:
V159 (sc4) versus G159 (z14/sc3) and S281 (sc4) versus P281 (z14/sc3).
 
Eucaryotic Expression of Neurotractin Isoforms
 
The complete insert of pSKII/sc4 was excised using XbaI and ApaI (par-
tial digest) and ligated into pBK-CMV that had been linearized with NheI
and ApaI to obtain pCMV/C11B3. In this step, the 
 
E
 
.
 
 coli
 
 promoter of
pBK-CMV which may interfere with eucaryotic expression was deleted.
To express the L-form of neurotractin, the COOH-terminal part of
pCMV/z14 was excised by digestion with NotI (partial) and MluI and sub-
cloned into NotI-MluI–linearized pCMV/C11B3 to obtain pCMV/C11A1.
Plasmids pCMV/C11B3 and pCMV/C11A1, which encode neurotractin-S
and -L, respectively, were transfected into COS cells as described previ-
ously (Spaltmann and Brümmendorf, 1996). To construct fusion proteins
of human IgG Fc domains with neurotractin, the extracellular domains of
neurotractin-L and -S were amplified from pCMV/C11A1 and pCMV/
C11B3, respectively, using the primers 5
 
9
 
-AAGAATTCCAGCGCGGAG-
 
CGGCGCGGAGAT-3
 
9
 
 and 5
 
9
 
-TTGAATTCTGATCCCATACTGGG-
CCGTACT-3
 
9
 
. Amplification products were subcloned via EcoRI into
plasmid pIG2 (Volkmer et al., 1998), and sequences were confirmed by the
dideoxy chain termination method. Expression in COS cells and purifica-
tion of fusion proteins was done as described (Brümmendorf et al., 1997).
 
Neurite Outgrowth Assays and Image Analysis
 
To isolate telencephalic cells, E8 telencephali were incubated for 20 min
at 37
 
8
 
C in HBSS with 1 mg/ml trypsin. Tissue was rinsed in HBSS, dissoci-
ated in DME and 10% FCS, and then cells were seeded at a density of
50,000 cells/cm
 
2
 
 in tissue culture dishes (Petriperm™; Bachofer). The
dishes had been precoated with 5 
 
m
 
l of test protein (12.5–100 
 
m
 
g/ml) for
4 h at 4
 
8
 
C, washed with HBSS, and blocked with DME and 10% FCS for
45 min at 37
 
8
 
C. Cultures were incubated for 40 or 72 h at 37
 
8
 
C, fixed, and
stained essentially as described (Treubert and Brümmendorf, 1998) using
mAb 5E directed to NCAM (Watanabe et al., 1986). To count attached
cells, nuclei were labeled with the DNA-staining reagent H33258 (Boeh-
ringer Mannheim). Neurite outgrowth was quantified as follows: images
containing nuclei of attached cells were captured separately from images
with neurons using appropriate filter settings (images with neurons were
edited manually because of a low signal-to-noise ratio). Images were then
processed by an automated procedure to count cell nuclei and neurites
and to determine neurite lengths essentially as detailed previously (Treu-
bert and Brümmendorf, 1998). In this study low cell densities and num-
bers of neurites allowed us to measure the exact lengths and numbers of
neurites and to normalize with respect to the number of attached cells.
Data were pooled from several independent experiments as follows. For
quantification of neurite initiation, 80 images (450 
 
3
 
 450 
 
m
 
m) with a total
of 2,800 attached cells were evaluated for 25 
 
m
 
g/ml neurotractin-L. For 50
 
m
 
g/ml L-form, 109 images (5,500 cells) were evaluated, for 100 
 
m
 
g/ml, 125
images (6,700 cells), for the S-form, 31 images (680 cells), and for Fc con-
trol substrate, 28 images (890 cells). To quantify neurite elongation, 61 im-
ages with a total of 202 neurites were processed for 25 
 
m
 
g/ml neurotrac-
tin-L, 102 images (483 neurites) for 50 
 
m
 
g/ml, and 118 images (683 neurites)
for 100 
 
m
 
g/ml neurotractin-L. Lower neurotractin-L concentrations in the
coating solution (12.5 
 
m
 
g/ml) did not result in significant neurite exten-
sion. Statistical significance of differences was evaluated using the Mann-
Whitney U Test implemented in the Statview program (Abacus Con-
cepts, Inc.)
 
Antibodies, Biochemistry, and Immunohistochemistry
 
Preparation of embryonic and adult chick brain plasma membranes, im-
munoblots, and release of GPI-linked proteins by phosphatidylinositol-
specific phospholipase C (PI-PLC) was performed as outlined previously
(Rathjen et al., 1987b, 1991; Wolff et al., 1989). Monoclonal antibodies di-
rected against a 45–55-kD glycoprotein fraction of GPI-linked neural pro-
teins from chicken brain were generated as described previously (Rathjen
et al., 1987a,b). To isolate both isoforms of neurotractin by immunoaffin-
ity chromatography from PI-PLC supernatants mAb NTRA-1 was cou-
pled to CNBr-activated Sepharose 4B (Pharmacia Biotech AB). NH
 
2
 
-
terminal and internal peptide sequences of neurotractin have been
determined essentially as reported previously (Volkmer et al., 1992).
Polyclonal antibodies to neurotractin were generated in rabbits by subcu-
taneous injection of 10 
 
m
 
g neurotractin in 2-wk intervals. N-linked carbo-
hydrates were cleaved from proteins with a mixture of endoglycosidase F
and peptide-
 
N
 
-glycosidase F of 
 
Flavobacterium meningosepticum
 
 (Taren-
tino and Plummer, 1994) according to instructions of the manufacturer
(Oxford GlycoSystems).
Generation and characterization of function-blocking polyclonal Fab
fragments directed to chicken neural IgSF members Ng-CAM, neurofas-
cin, Nr-CAM, F11, axonin-1, NCAM, or gicerin (Rathjen et al., 1987a,b;
Morales et al., 1993; Taira et al., 1994; Volkmer et al., 1998), and of poly-
clonal antibodies that recognize cell surface–expressed CEPU-1 or LAMP
(Spaltmann and Brümmendorf, 1996; Brümmendorf et al., 1997) has been
reported in previous studies.
Incubation of chicken eggs, preparation of tissue sections and immu-
nofluorescence analysis were done as outlined in detail previously (Spalt-
mann and Brümmendorf, 1996).
 
In Situ Hybridization Analyses
 
To generate probes specific for the second and the third Ig-like domain of
neurotractin, the corresponding sequences were amplified by PCR with
the primer pairs 5
 
9
 
-AAGGATCCAACAATGCAGGTGCACCTCAC-
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3
 
9
 
/5
 
9
 
-TTGAATTCGGACTGAGACGTCGTTTTCTGC-3
 
9
 
 and 5
 
9
 
-AAG-
GATCCCACAATTCAGGAACTTAAATCC-3
 
9
 
/5
 
9
 
-TTGAATTCGAG-
GCAGGCTGGCATTGGTCA-3
 
9
 
, respectively, using plasmid pCMV/
C11A1 as a template and the products were subcloned via BamH1/EcoRI
into plasmid pKSII (Stratagene). The plasmids were linearized and in
vitro transcription was performed on 1 
 
m
 
g of template DNA/reaction
using T3- (antisense strand) or T7- (sense strand) RNA polymerase
(Fermentas) and a digoxigenin (DIG) nucleotide labeling mixture
(Boehringer Mannheim). The resulting RNA was purified on Sephacryl
columns (Pharmacia) and the concentration was estimated on an aga-
rose gel.
Brain tissue was dissected from different embryonic stages and either
directly frozen and cut on a cryostat (see Fig. 4, A and B) or fixed at first
overnight in PBS/4% paraformaldehyde followed by PBS/30% sucrose
(see Fig. 4 C). Sections were postfixed in PBS/4% paraformaldehyde for
10 min, washed twice in PBS/0.1% diethylpyrocarbonate for 15 min and
equilibrated in 5
 
3
 
 SSC for 15 min. Prehybridization was performed for
2 h in hybridization solution (50% formamide, 5
 
3
 
 SSC, 40 
 
m
 
g/ml dena-
tured salmon sperm DNA) at 58
 
8
 
C followed by overnight hybridization in
the same buffer containing 0.4 
 
m
 
g/ml DIG-labeled RNA at 58
 
8
 
C. Sections
were washed in 2
 
3
 
 SSC at room temperature (RT) for 30 min, in 2
 
3
 
 SSC
at 65
 
8
 
C for 1 h, in 0.2
 
3
 
 SSC for 1 h, in PBS/0.1% Tween 20 at 65
 
8
 
C for 10
min, and finally in PBS/0.1% Tween 20 at RT for 10 min. Blocking was
performed in PBS/0.1% Tween 20/0.5% skimmed milk powder (contain-
ing 20% sheep serum) for 2 h at RT followed by anti-DIG alkaline phos-
phatase-conjugated antibody (Boehringer Mannheim; 1:2,500 diluted in
the same buffer) at 4
 
8
 
C overnight. Excess antibody was washed off in
PBS/0.1% Tween 20 (three times for 30 min at RT), sections were equili-
brated in alkaline phosphatase reaction buffer (100 mM Tris-HCl, 100 mM
NaCl, and 50 mM MgCl
 
2
 
, pH 9.5), and then colorized in the same buffer
containing 340 
 
m
 
g/ml NBT and 175 
 
m
 
g/ml BCIP overnight at RT. The
color reaction was stopped in PBS, sections were dehydrated in ethanol,
and then mounted in Eukitt (Kindler).
 
Binding Assays with Recombinant Fusion Proteins
 
Binding of Fc fusion proteins to transfected CHO and COS cells as well as
expression plasmids for chicken CEPU-1 and chicken LAMP have been
described previously (Spaltmann and Brümmendorf, 1996; Brümmendorf
et al., 1997). Transfection efficiencies and cell surface expression levels
were found to be indistinguishable for CEPU-1, LAMP, and NTRA-L, as
examined by immunofluorescence analysis using polyclonal antibodies
followed by quantification with an image analysis system which has been
described previously (Treubert and Brümmendorf, 1998). To estimate
binding constants, transfected CHO cells were exposed to increasing con-
centrations of purified neurotractin-Fc fusion proteins, followed by an ex-
cess of Cy3-conjugated secondary antibody directed to human IgG (Di-
anova). Fluorescence intensity was quantified within the linear response
range of the image analysis system and background fluorescence intensity
(measured with the same fusion proteins under the same conditions on
untransfected cells) was subtracted. To estimate 
 
K
 
D
 
 values, binding data
were fitted to a linearized form of a titration curve as introduced by Heyn
and Weischet (1975) and detailed by Bisswanger (1979).
 
Results
 
Neurotractin Is a Novel Neural Member of the
Ig Superfamily
 
To identify novel members of the IgSF in the developing
brain we defined sequence patterns characteristic for
members of this superfamily which has been described in
a previous study (Spaltmann and Brümmendorf, 1996).
These were used to generate libraries of sequence frag-
ments of neural IgSF members by PCR of reverse-tran-
scribed embryonic chick brain mRNA. Sequencing of one
of our initial PCR products indicated that it represents a
novel member of the IgSF and it was therefore used to iso-
late cDNA clones by standard DNA hybridization proce-
dures. Three clones were obtained which encode two iso-
forms of a novel IgSF protein, termed neurotractin (Fig. 1
 
A). Both isoforms reveal a hydrophobic COOH-terminal
segment which is compatible with anchorage to the plasma
membrane via a GPI anchor (Udenfriend and Kodukula,
1995). The large isoform, referred to as neurotractin-L, is
composed of three Ig-like domains and the smaller iso-
form, neurotractin-S, lacks the third, membrane-proximal,
Ig-like domain (Fig. 1 B).
The overall domain organization and sequence align-
ments indicate that neurotractin belongs to a subgroup of
neural GPI-linked IgSF proteins, termed IgLON subgroup
(for LAMP, opioid-binding cell adhesion molecule, neu-
rotrimin; Pimenta et al., 1995). Detailed sequence analyses
including all known members of this subgroup reveals that
neurotractin represents a novel member of this subgroup
and can not be considered as the chicken equivalent of one
of the mammalian subgroup members (Fig. 1 C).
To analyze biochemical features and the histological dis-
tribution of neurotractin we used two mAbs, namely
NTRA-1 and NTRA-2 (Fig. 2 A). Whereas mAb NTRA-1
reacts with both isoforms, mAb NTRA-2 binds only to the
larger form, neurotractin-L, suggesting its epitope is lo-
cated within the third Ig-like domain. mAb NTRA-1 was
used to isolate both isoforms from PI-PLC supernatants of
brain plasma membranes by immunoaffinity chromatogra-
phy. The immunoaffinity isolate was found to comprise
two bands, a 50-kD band and a fainter stained 37-kD band
(Fig. 2 B, lane 1) that comigrated in SDS-PAGE with neu-
rotractin isoforms expressed in COS cells, suggesting that
neurotractin-L is dominating in brain in comparison to the
S-form. Members of the IgLON subgroup are found to be
highly glycosylated. To determine the degree of N-glyco-
sylation, neurotractin isoforms were subjected to enzy-
matic deglycosylation which reduced the molecular masses
to 38 and 30 kD, respectively (Fig. 2 B, lane 2). Thus,
 
z
 
24% of the molecular mass of glycosylated neurotrac-
tin-L represents N-linked carbohydrates.
Taken together, neurotractin is a novel GPI-linked
member of the neural IgLON subgroup of the IgSF which
occurs in two isoforms, a larger 50-kD form and a less
abundant small form of 37 kD.
 
Expression of Neurotractin Increases during 
Development and Persists in Adult Brain
 
To obtain indications of the expression pattern of neu-
rotractin, different brain regions and developmental stages
were examined by Western blot analyses. Neurotractin
was detectable in embryonic retina, telencephalon, tec-
tum, cerebellum and diencephalon (Fig. 2 C, lanes 1–10).
The highest level of neurotractin expression was found in
telencephalon whereas the lowest level was determined in
retina. In all brain regions examined, expression of the
L-form as well as that of the S-form increases during de-
velopment. In all regions and at all developmental stages
examined, neurotractin-L seems to be more abundant
than the S-form which is in line with the relationship ob-
served in the immunoaffinity isolate (Fig. 2 B, lane 1).
To examine whether neurotractin is a brain-specific pro-
tein, solubilized samples of embryonic liver, muscle and
lung tissue were compared with a total brain sample in
SDS-PAGE followed by Western blot analyses. Whereas
neurotractin can be identified in embryonic brain (Fig. 2
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C, lane 11) it is undetectable in embryonic liver (Fig. 2 C,
lane 12), muscle or lung (not shown) which suggests that
neurotractin is a brain-specific protein.
 
Neurotractin Is an Axonal Cell Surface Molecule on 
Subsets of Central Nervous System Axon Tracts
 
To characterize the histological distribution of neurotrac-
tin, distinct chicken brain regions of different develop-
mental stages were examined by immunohistochemical
analyses using mAb NTRA-1 which is directed to both
neurotractin isoforms (Fig. 2 A). At embryonic day 8, neu-
rotractin is expressed on tectofugal axons in the stratum
album centrale of the developing tectum mesencephali
(Fig. 3 C). By contrast, neurotractin could not be detected
in the plexiform layers or the optic fiber layer of the retina
(not shown). It was also undetectable on retinal ganglion
cell axons on their pathway to the tectum (Fig. 3, E and
G). Therefore, in the retinotectal system at embryonic day
8, neurotractin is restricted to tectal efferents but is lacking
on tectal afferents.
On their pathway from the retina to the tectum, retinal
ganglion cell axons cross the midline at the optic chiasm.
In this region, they closely approach another axon tract,
the supraoptic decussation which represents a major inter-
hemispheric axon tract in the chicken located at the floor
of the diencephalon (Ehrlich et al., 1988 and references
cited therein). Interestingly, neurotractin is found to be
strongly expressed on axons of the supraoptic decussation
but it is undetectable on the adjacent retinal ganglion cell
axons which demonstrates that neurotractin is restricted to
subsets of axon tracts (Fig. 3, E and G). The supraoptic de-
cussation is not the only neurotractin positive axon tract
which crosses the midline. Neurotractin was also found on
axons of the anterior commissure (Fig. 3, D and F) which
is situated in the ventral forebrain and which represents
the largest intertelencephalic pathway in chicken (Ehrlich
and Mills, 1985).
 
Figure 1
 
. Primary structure, domain models of neurotractin and
sequence relationship to other IgLON members. (A) Primary
structure of neurotractin. The predicted NH
 
2
 
-terminal signal
peptide and the COOH-terminal hydrophobic segment are un-
derlined by dashed lines and arrows indicate the mature NH
 
2 
 
ter-
minus and COOH terminus. Putative N-linked glycosylation sites
are underlined and characteristic cysteine residues of Ig-like do-
mains are labeled by circles. To obtain independent evidence that
the protein which had been isolated by immunoaffinity chroma-
tography (see Fig. 2 B, lane 1) is identical with that predicted by
the cDNA clones, a sample of it as well as peptides derived from
a tryptic digest were subjected to Edman degradation. Evalua-
tion of the partial internal as well as the NH
 
2
 
-terminal sequence
(indicated by dotted lines) confirms that they match this cDNA
sequence. The alternatively spliced and L-form–specific third Ig-
like domain is indicated by brackets. The sequences of S-form
and L-form are available from GenBank/EMBL/DDBJ under ac-
cession numbers AJ132998 and AJ132999, respectively. (B) Do-
main models of neurotractin-L (large) and -S (small). Ig-like do-
mains are drawn as loops that are closed by disulfide bridges,
putative N-linked glycosylation sites are shown as lines ending
with dots and the GPI-anchor is represented by an arrow. (C)
Neurotractin is a novel protein belonging to the IgLON sub-
group. Sequence relationship of neurotractin-L to other mem-
bers of the IgLON subgroup was examined with the PILEUP
program from the GCG package (University of Wisconsin, Madi-
son, WI) and sequences have been taken from Schofield et al.,
1989; Lippman et al., 1992; Shark and Lee, 1995; Struyk et al.,
1995; Pimenta et al., 1995, 1996a; Spaltmann and Brümmendorf,
1996; Brümmendorf et al., 1997; Hancox et al., 1997. GP55-A is a
partial sequence lacking most likely a short stretch at the NH
 
2
 
terminus (Wilson et al., 1996). ch, chicken; hu, human; bo, bo-
vine; rt, rat.
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In addition to axons crossing the midline, neurotractin is
also expressed in longitudinal axon tracts, for instance on
axon bundles in E7 diencephalon (Fig. 3 A) or on longitu-
dinal axons in the spinal cord (Fig. 3 B). At embryonic day
9, neurotractin expression is pronounced in a small dorso-
lateral subpopulation of axons in the spinal cord. Later in
development, however, this restriction is lost and neu-
rotractin is found on all longitudinal spinal cord axons
(data not shown).
As described above, neurotractin occurs in two isoforms
which may be differentially expressed in the developing
nervous system. Since the L-form–specific mAb NTRA-2
did not recognize the protein in tissue sections we per-
formed in situ hybridizations to investigate a possible dif-
ferential distribution of the two forms. Two neurotractin
probes, one which is L-form–specific and one which de-
Figure 2. Neurotractin occurs in two isoforms and is upregulated
in development. (A) Lysates of COS cells that had been trans-
fected with the L-form (lanes 1 and 4) or S-form (lanes 2 and 5)
of neurotractin were compared with mAb NTRA-1 immunoaf-
finity isolate (lanes 3 and 6) by SDS-PAGE. In Western blots
mAb NTRA-1 stains both isoforms as well as both bands in the
immunoaffinity isolate (lanes 1–3) whereas mAb NTRA-2 de-
tects only the L-form and the larger band of the immunoaffinity
isolate (lanes 4–6). (B) Neurotractin that was isolated by immu-
noaffinity chromatography from adult chicken brains using mAb
NTRA-1 was subjected to SDS-PAGE and detected by silver
staining. Neurotractin resolves in two bands, one of 50 kD and
one of 37 kD (lane 1). Deglycosylation by endoglycosidase F/pep-
tide-N-glycosidase F leads to a reduction of the molecular mass
to 38 and 30 kD, respectively (lane 2). The 40-kD component
(lane 2) represents a deglycosylation intermediate. (C) Samples
of different regions of embryonic chick brain from early and late
developmental stages were solubilized in SDS-PAGE sample
buffer, resolved by SDS-PAGE, and probed with mAb NTRA-1
directed to neurotractin (each lane represents 30 ml of 1% brain
homogenate). Comparison of samples from early stages with
those from late stages shows that in each analyzed brain region
neurotractin expression increases during development (lanes
1–10). Neurotractin can be detected in total brain but not in liver
(lanes 11 and 12). E, embryonic day; RE, retina; TL, telencepha-
lon; TE, tectum; CE, cerebellum; DI, diencephalon; TB, total
brain; LI, liver.
Figure 3. Neurotractin expression on subsets of embryonic axon
tracts. Immunohistochemical analysis of E7 diencephalon with
mAb NTRA-1 shows crosscut longitudinal neurotractin positive
axon tracts (A). In the E9 spinal cord dorsolateral longitudinal
axons show strong neurotractin expression (B). In tectum of em-
bryonic day 8 neurotractin is found on axons of the stratum al-
bum centrale (C). Staining of a horizontal section of E9 ventral
forebrain with mAb NTRA-1 shows strong expression of neu-
rotractin on axons of the anterior commissure (D). This axon
tract is also discernible as a nuclei-poor zone as revealed by DNA
staining (F). A horizontal section at the level of the E9 optic chi-
asm reveals neurotractin expression on axons of the supraoptic
decussation (E). Bisbenzimide staining of cellular nuclei in the
same section outlines the axons of the supraoptic decussation as
well as those of retinal ganglion cells in the optic chiasm as an ex-
tended nuclei-poor region (G). Note that neurotractin is re-
stricted to the supraoptic decussation and is lacking on the retinal
ganglion cell axons. At E9, the supraoptic decussation is not yet
subdivided into the dorsal, ventral and subventral regions which
can be distinguished later in development (Ehrlich et al., 1988).
VH, ventral horn; DH, dorsal horn; DF, dorsal funiculus; SAC,
stratum album centrale; d, dorsal; v, ventral; CA, commissura an-
terior; SD, supraoptic decussation; OC, optic chiasm.
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tects both forms of neurotractin mRNA were generated.
A direct comparison of L-form versus S-form is not possi-
ble because the S-form sequence is completely contained
within the L-form sequence. Both probes did not reveal
detectable differences in the distribution of L-form mRNA
versus total neurotractin mRNA in distinct regions of de-
veloping chicken brain, for instance in spinal cord (Fig. 4
A), in subpopulations of neurons in ventral telencephalon
(Fig. 4 B), in the cerebellum (Fig. 4 C), and in the tectum
(data not shown). Thus, the in situ hybridizations suggest
that there are no cells which are exclusively expressing the
L-form and also support our conclusions drawn from the
immunohistochemical analyses that neurotractin expres-
sion is restricted to subpopulations of neurons.
Taken together, these results demonstrated that neu-
rotractin is expressed by subpopulations of neurons in dis-
tinct regions of the developing chicken brain and that it is
an axonal glycoprotein that appears to be restricted to
subsets of commissural and longitudinal axon tracts.
 
Neurotractin-L Promotes Neurite Extension of 
Telencephalic Neurons
 
Subpopulations of axons within the anterior commissure,
the supraoptic decussation, and longitudinal diencephalic
pathways that show prominent neurotractin expression
(Fig. 3) originate and terminate in the telencephalon. This
might suggest that neurotractin plays a role in fascicula-
tion and/or elongation of telencephalic axons within these
pathways. Thus, to get first insights into the function of
neurotractin, we tested if it is able to promote neurite out-
growth of telencephalic neurons. Recombinant forms of
neurotractin fused to the Fc domains of human IgG1 (Fig.
5, F and G) were immobilized on tissue culture dishes and
were used as substrates for embryonic day 8 telencephalic
cells. We examined long-term cell attachment, neurite ini-
tiation, and neurite elongation of telencephalic neurons by
measuring the number of adhering cells, the number of
neurites per 100 cells and average neurite length, respec-
tively, using an automated image analysis procedure (see
Materials and Methods). These experiments showed that
neurotractin-L fusion protein promotes attachment and
neurite extension of telencephalic cells (Fig. 5, A, C, and
D), whereas on Fc control substrate cell attachment was
low and neurite outgrowth was undetectable (Fig. 5, B–D).
In contrast, neurotractin-S mediated only weak adhesion
which was within the same range as that measured on Fc
control substrate and did not induce neurites.
Quantification of the neurotractin-L–mediated neurite
outgrowth response after 40 h of incubation showed that
the number of neurites per 100 cells increased in a dose-
dependent manner (Fig. 5 D) suggesting that neurotractin
modulates neurite initiation. On average only 
 
z
 
1 of 10
cells was found to elaborate a neurite suggesting that the
responsive neurons might represent a subpopulation of
telencephalic cells. To investigate if prolonged incubation
might recruit a larger neuronal subpopulation to extend
neurites, cultures were evaluated after 72 h. However, no
additional increase in the number of neurites per 100 cells
could be observed for the highest neurotractin concentra-
tion that was tested (data not shown).
A neurite outgrowth–promoting molecule may regulate
the initiation of neurites and/or their elongation. There-
fore, we investigated if immobilized neurotractin has an
impact on the average length of telencephalic neurites, in
addition to its effect on neurite initiation. However, no sig-
nificant effect of increasing neurotractin-L amounts on the
average neurite length could be demonstrated after 40 h
(Fig. 5 E) or 72 h (data not shown) suggesting that neu-
rotractin primarily influences the initiation of neurites of
telencephalic neurons in vitro. Consistently, the average
neurite length increased by 
 
,
 
10% from 40 to 72 h of incu-
bation (data not shown).
As a first step to characterize the cellular receptor on
telencephalic neurons responsible for the neurite out-
growth–promoting activity of neurotractin-L, polyclonal
antibodies specific for various cell surface proteins were
applied in these in vitro assays. We tested antibodies di-
rected to L1 subgroup members (Ng-CAM, neurofascin,
and Nr-CAM), F11 subgroup members (F11 and axonin-
1), IgLON subgroup members (LAMP and CEPU-1),
NCAM, or gicerin. None of these antibodies which have
been previously documented to interfere functionally in
distinct experimental paradigms using chicken neurons
(Rathjen et al., 1987a,b; Morales et al., 1993; Taira et al.,
1994; Volkmer et al., 1998), or to recognize the respective
proteins on cell surfaces (Spaltmann and Brümmendorf,
1996; Brümmendorf et al., 1997), blocked neurite out-
growth on neurotractin-L (data not shown). Therefore,
the cellular receptor on telencephalic neurons that medi-
ates the neurite outgrowth–promoting activity of neu-
rotractin-L remains unknown at present. To characterize
the neurotractin-responsive cells we have analyzed their
profile of expression of known adhesion proteins. Consis-
Figure 4. Localization of neurotractin mRNA in the developing
nervous system. In situ hybridizations with two different neu-
rotractin antisense probes: one derived from the second Ig-like
domain which detects both isoforms (first column) and one de-
rived from the third Ig-like domain which is L-form specific (sec-
ond row). Both probes gave essentially the same staining patterns
in chick E12 cervical spinal cord (A), in a subpopulation of neu-
rons in E12 ventral telencephalon (B), and in the internal granu-
lar layer of E16 cerebellum (C). Control hybridizations with
sense probes did not give significant signals (third column).
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tent with the above-mentioned antibody perturbation ex-
periments, these responding cells are NCAM and F11 pos-
itive, but are, however, negative for NgCAM, neurofascin,
NrCAM, and axonin-1 (data not shown).
 
Interaction of Neurotractin with CEPU-1 and
with LAMP
 
Several Ig superfamily members on axons reveal ho-
mophilic and/or heterophilic binding to other IgSF mem-
bers within the same or across plasma membranes to reg-
ulate cellular interactions (Brümmendorf and Rathjen,
1996; Drescher et al., 1997; Sonderegger, 1997). To further
characterize the molecular function of neurotractin iso-
forms we examined if recombinant neurotractin interacts
with itself or with other neural members of the IgSF. To
this end, purified Fc fusion proteins of neurotractin-L and
-S were incubated with CHO cell transfectants that ex-
press putative interaction partners on their surface and, af-
ter washing, bound fusion proteins were detected with flu-
orochrome-conjugated secondary antibodies specific for
their Fc portion. Soluble neurotractin-L fusion protein was
found to bind strongly to CEPU-1 transfectants and, in
comparison, weakly to LAMP transfectants, whereas no
homophilic binding to neurotractin-L transfectants could
 
Figure 5
 
. Neurotractin-L promotes neurite outgrowth and cell
attachment of telencephalic neurons. (A) Cells isolated from E8
telencephalon attach to a neurotractin-L substratum which pro-
motes neurite outgrowth. (B) Cell attachment to the control sub-
strate consisting of Fc protein without neurotractin domains is
shown for comparison. (C) Density of telencephalic neurons ad-
hering to different substrates. Fc fusion proteins were coated as
follows: neurotractin L-form with 25 
 
m
 
g/ml (1), 50 
 
m
 
g/ml (2), and
100 
 
m
 
g/ml (3), Fc control protein (4), and neurotractin S-form (5)
with 100 
 
m
 
g/ml. Data were pooled from independent experi-
ments, histogram bars show median values, error bars represent
SEM, and the number of analyzed images (450 
 
m
 
m 
 
3
 
 450 
 
m
 
m) is
given in parentheses. The difference between Fc control protein
and 25 
 
m
 
g/ml neurotractin-L is statistically significant (
 
P
 
 
 
5 
 
0.003,
Mann Whitney U test). (D) Neurotractin-induced telencephalic
neurite outgrowth after 40 h of incubation on Fc fusion proteins
coated as in C. The differences between Fc control protein and 25
 
m
 
g/ml neurotractin-L (
 
P
 
 
 
, 
 
0.001), between 25 
 
m
 
g/ml and 50 
 
m
 
g/
ml (
 
P
 
 
 
, 
 
0.05), and between 50 
 
m
 
g/ml and 100 
 
m
 
g/ml (
 
P
 
 , 0.05)
are statistically significant (Mann Whitney U test). Lower neu-
rotractin-L concentrations in the coating solution (12.5 mg/ml)
did not result in significant neurite extension above background
values (data not shown). (E) Increasing amounts of neurotractin
do not influence the average length of telencephalic neurites. Fc
fusion protein of neurotractin L-form was coated as indicated in
C. (F) SDS-PAGE (10%) of fusion proteins used in neurite out-
growth experiments and binding studies followed by silver stain-
ing. Purified Fc fusion proteins of L-form (lane 2) and S-form
(lane 3) neurotractin reveal the expected molecular masses of 80
and 65 kD, respectively. The Fc domains are resolved in a 39-kD
component and a 36-kD degradation product (lane 1). (G) SDS-
PAGE (10%) and Western blot analyses show that neurotrac-
tin-L (lane 2), neurotractin-S (lane 3), and the Fc domains (lane
1) can be detected with polyclonal Fc domain-specific antibodies.
The 36-kD component (lanes 2 in F and G) which can also be ob-
served in the Fc control protein (lanes 1 in F and G) is a degrada-
tion product. Neurotractin-specific polyclonal antibodies identify
both neurotractin isoforms (lanes 5 and 6) but do not react with
the Fc domains (lane 4).
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be detected (Fig. 6 A). The S-form of neurotractin also in-
teracts with CEPU-1, however, binding was clearly weaker
than that of the L-form while binding to LAMP could not
be detected by this method. As a control, interaction of
neurotractin-L with other IgSF members was examined
under the same conditions but no binding could be ob-
served to F11 (Fig. 6 D), NgCAM, axonin-1, neurofascin
(data not shown), or GPI-linked Fc domains alone (Fig. 6
E). As an additional control, CEPU-1–expressing CHO
cells were treated with PI-PLC to release CEPU-1 from
the cell surface and were then incubated with neurotrac-
tin-L fusion protein. A strongly decreased binding to PI-
PLC treated transfectants supports the interpretation that
neurotractin-L binds to CEPU-1 on the cell surface and
not unspecifically to other cell surface components (Fig. 6,
B and C). Furthermore, binding of soluble neurotractin-L
to surface-expressed CEPU-1 and LAMP could also be
demonstrated with other eucaryotic cells, namely trans-
fected COS cells (Fig. 6, G and F).
To estimate the apparent dissociation constant for the
neurotractin-L–CEPU-1 interaction, we quantified bind-
ing of neurotractin-L fusion protein to CEPU-1 which was
expressed on the surface of transfected CHO cells. In this
assay system, one of the interacting proteins is in a native
and membrane-bound form and binding of the interacting
partner can be monitored by immunofluorescence analy-
sis and quantified by digital image processing. Binding
of neurotractin-L fusion protein to CEPU-1–transfected
CHO cells was saturable and gave an apparent dissocia-
tion constant of 3 3 1028 M (Fig. 7). The interactions of
neurotractin-L with LAMP and of the S-form with CEPU-1
could not be reliably quantified but were estimated to be
at least five times weaker than L-form binding to CEPU-1
(Fig. 6 A). Furthermore, no significant fluorescence signal
could be observed if soluble Fc control protein was incu-
bated with CEPU-1–transfected cells (data not shown).
In conclusion, neurotractin-L interacts with the structur-
ally related molecule CEPU-1 and, though more weakly,
with LAMP, whereas neither homophilic binding nor
binding to other neural IgSF members could be detected.
However, these interactions are not required for neu-
rotractin-L–mediated neurite initiation as revealed by
antibody perturbation experiments (see above) which sug-
gests that the neurotractin–CEPU-1 or the neurotractin–
LAMP binding might be implicated in other cellular activ-
ities.
Discussion
A Family of GPI-linked Neural Cell Surface Proteins 
with Three Ig-like Domains
In this study, we identified neurotractin as a novel GPI-
linked neural member of the IgSF with three Ig-like do-
mains. It is associated with specific axon tracts and is im-
plicated in neurite initiation as demonstrated by in vitro
assays. Comparison of the neurotractin sequence with se-
quences in GenBank database revealed that it shows 48–
56% sequence identity to members of a neural subfamily
of the IgSF which is termed IgLON subgroup (Pimenta
et al., 1995). This group comprises limbic system-associ-
ated membrane protein (LAMP) (Pimenta et al., 1995,
1996a), opioid-binding cell adhesion molecule (OBCAM;
Schofield et al., 1989; Lippman et al., 1992; Shark and Lee,
1995), and neurotrimin (Struyk et al., 1995) in mammalia
as well as CEPU-1 (Spaltmann and Brümmendorf, 1996),
Figure 6. Molecular interaction of neurotractin with CEPU-1
and LAMP. (A) Neurotractin-L (first row), CEPU-1 (middle
row), and LAMP (bottom row) were expressed on the surface of
CHO cells by transient transfection. Confluent layers of cells
were incubated with 10 mg/ml of purified Fc fusion proteins of
neurotractin L-form (left column) and S-form (right column). Af-
ter washing, Fc domains of fusion proteins were detected by Cy3-
conjugated secondary antibody directed to human IgG. Control
experiments showed that the percentage of transfected cells and
their surface expression levels were indistinguishable for NTRA-L,
CEPU-1, and LAMP. CHO cells expressing CEPU-1 on their
surface that had been preincubated with PI-PLC (B) or control
buffer (C) were tested with COS cell supernatants containing
neurotractin-L Fc fusion protein. CHO cells expressing F11 (D)
or GPI-linked Fc domains (E) do not bind neurotractin-L fusion
protein. Furthermore, COS cells which express CEPU-1 (G) or
LAMP (F) on their surface were also found to bind soluble re-
combinant neurotractin-L.
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LAMP (chLAMP/AvGP50/E19S; Wilson et al., 1996;
Brümmendorf et al., 1997; Hancox et al., 1997), GP55-A
(Wilson et al., 1996), and neurotractin (this study) which
have been identified in chicken (Fig. 1 C). All IgLON sub-
group members share with neurotractin the 3-domain or-
ganization, the plasma membrane attachment via GPI,
and the restricted expression in partially overlapping re-
gions of the nervous system (Struyk et al., 1995; Pimenta
et al., 1996b; Wilson et al., 1996; Brümmendorf et al., 1997;
Hancox et al., 1997). Furthermore, neurotractin has 26–
29% sequence identity with distinct Drosophila proteins,
including lachesin (Karlstrom et al., 1993), amalgam (See-
ger et al., 1988), and klingon (Butler et al., 1997).
Pairwise comparisons of single domains of IgLON mem-
bers shows that the corresponding domains are most
highly conserved between different molecules (data not
shown). This colinear relationship of individual domains
suggests an evolutionary origin of these proteins from a
common ancestor. LAMP is currently the most thoroughly
characterized representative of this subgroup. It reveals a
restricted pattern of expression in functionally related ar-
eas of the nervous system and might serve as a guidance
cue during the development of the septo-hippocampal
pathway (Keller et al., 1989) and the hippocampal mossy
fiber projection (Pimenta et al., 1995). Cloning of LAMP
from human (Pimenta et al., 1996a), rat (Pimenta et al.,
1995), and chicken (Wilson et al., 1996; Brümmendorf et al.,
1997; Hancox et al., 1997) revealed that it is highly con-
served in evolution, e.g., human LAMP shows 99 and 91%
sequence identity with the rat and chicken proteins, re-
spectively. The structural similarity of vertebrate IgLON
molecules and their spatiotemporal expression pattern
suggests that they might have related functions in the con-
text of cell–cell interactions in nervous system histogenesis
and in the adult brain.
Binding of Neurotractin to the GPI-linked Proteins 
CEPU-1 and LAMP
Whereas we could demonstrate that neurotractin-L is in-
volved in initiation of telencephalic neurite growth, the ax-
onal receptor protein important for this activity could not
be identified at present. Our attempts to characterize pro-
teins that interact with neurotractin resulted in the finding
that neurotractin-L Fc fusion protein binds to CEPU-1
and, more weakly, to LAMP (Fig. 6). Therefore, it appears
to be a characteristic feature of IgLON molecules that
some members of this subgroup bind to other members of
the same subgroup, however, not to other IgSF proteins. A
KD of 3 3 1028 M was measured for the binding of neu-
rotractin to the GPI-linked molecule CEPU-1 (Fig. 7), an
affinity that is lower than that usually reported for soluble
polypeptide ligands that bind to cell surface receptors, for
instance the neurotrophins (Dechant et al., 1994). How-
ever, cell–cell communication via membrane-bound li-
gands is likely to depend not only on receptor affinity but
also on avidity effects and receptor density. Indeed, other
receptors which also interact with membrane-bound li-
gands have binding constants which are comparable to
that measured for neurotractin. For example, Fc fusion
proteins of the Eph-like receptor tyrosine kinases that
bind to cell surface ligands, termed ephrins, show dissocia-
tion constants of 4 3 10210 M to 4 3 1028 M (Gale et al.,
1996; Beckmann et al., 1994). Nevertheless, these KD val-
ues should not be overinterpreted. On the one hand, po-
tential bivalency of Fc fusion proteins may decrease their
dissociation rate constant which may lead to overesti-
mated affinities. On the other hand, analyses using soluble
ligands most likely underestimate the true avidity between
receptors and membrane bound ligands in their mem-
brane-associated state. Regardless, the interaction of neu-
rotractin with CEPU-1 is of a strength which is of physio-
logical relevance in other receptor/ligand systems. The
biological functions of the neurotractin–CEPU-1 or the
neurotractin–LAMP interactions are currently unknown.
Our antibody perturbations experiments indicate that they
are not required for neurite extension of telencephalic
neurons on immobilized neurotractin. However, it is con-
ceivable that these interactions are important for other
neurons, in contrast with the telencephalic neurons used
here. For example, CEPU-1, which is expressed by Pur-
kinje cells, and neurotractin are also colocalized in the
molecular layer of the cerebellum suggesting that the neu-
rotractin–CEPU-1 interaction may play a role in develop-
ment of the Purkinje cell dendritic tree.
Neurotractin May Participate in the Regulation of 
Neurite Outgrowth in the Developing Brain
Cell surface molecules that promote neurite outgrowth
can be interpreted as membrane-bound neuronal differen-
tiation factors because neurite initiation and elongation
are part of the neuronal differentiation program. For in-
stance, an outgrowth-initiating molecule that is restricted
to a particular cortical layer may influence neuronal differ-
entiation of precursor cells invading this layer and switch
on dendritic growth. On the other hand, a protein that
promotes elongation of neurites may provide a permissive
Figure 7. Equilibrium binding of recombinant neurotractin.
CHO cell transfectants expressing CEPU-1 were incubated with
increasing concentrations of neurotractin fusion proteins, fol-
lowed by a constant saturating amount of fluorochrome-conju-
gated Fc domain–specific antibody. Average fluorescence inten-
sity that was measured in at least three independent experiments
is given. Soluble Fc control protein gave a signal of ,5 fluores-
cence units if applied to CEPU-1 transfectants at a concentration
of 6.2 mM under the same conditions.
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environment for advancing growth cones. Our in vitro
analyses suggest that neurotractin-L is more likely to be
related to neurite initiation rather than elongation for two
reasons. First, within 40 h of incubation we observed a
dose-dependent influence on the number of neurites per
100 cells but no significant impact on the average length of
the neurites (Fig. 5). Second, we did not observe a signifi-
cant increase of average neurite length between 40 and 72 h
of incubation (data not shown).
Our observation that neurotractin has a stronger effect
on neurite initiation than on neurite elongation appears to
be inconsistent with its expression in axon tracts (Fig. 3)
that suggests a role in neurite elongation. However, neu-
rotractin is only one component of a complex network of
interacting receptors and ligands that regulate neurite out-
growth in vivo and it is reasonable to assume that other
important factors are missing in our in vitro assay system.
Thus, a more conclusive interpretation of the role of neu-
rotractin in the context of neurite outgrowth requires
additional studies, for instance antibody perturbation ex-
periments in ovo or histological analyses of neurotrac-
tin-deficient knockout mice.
Other hints to the putative role of neurotractin in neuro-
histogenesis come from functional analyses of structurally
related proteins. Many members of the IgSF that are ex-
pressed in the nervous system are implicated in processes
like neurite outgrowth (Brümmendorf and Rathjen, 1995;
Kamiguchi and Lemmon, 1997), fasciculation (Van Vac-
tor, 1998), and guidance (Deiner et al., 1997; Stoeckli and
Landmesser, 1998; Kidd et al., 1998). In particular, neu-
rotractin is closely related to LAMP (Pimenta et al., 1995),
which has been shown to induce neurite outgrowth from
specific subpopulations of neurons: transfected CHO cells
that express LAMP on their surface have only weak ef-
fects on neurons from olfactory bulb or visual cortex but
promote neurite outgrowth from perirhinal and hippo-
campal neurons significantly (Pimenta et al., 1995; Zhu-
kareva et al., 1997). This is reminiscent to neurotractin
which also promotes outgrowth only of subsets of neurons,
in this case subpopulations of telencephalic neurons. Fur-
ther experiments are needed to characterize the neu-
rotractin-responsive subpopulations of neurons in the de-
veloping brain and to identify the receptor(s) involved in
the outgrowth response.
Neurotractin Occurs in Two Isoforms which Are 
Upregulated in Development
Neurotractin is expressed in two isoforms, termed L-form
and S-form, differing with respect to the presence of the
membraneproximal Ig-like domain (Fig. 1 B). Both forms
show the same spatiotemporal expression profile, as exam-
ined by Western blot analyses (Fig. 2 C) and also at the
level of in situ hybridization analyses (Fig. 4). Alternative
splicing of complete Ig-like domains has not been ob-
served previously for IgLON molecules and its functional
significance remains unclear at present. One possible rea-
son for expression of different isoforms might be that they
differ functionally, for instance with respect to binding of
receptors and ligands. In this regard it is of interest that
only the L-form has been found to mediate adhesion and
neurite initiation of telencephalic neurons and that the
L-form binds stronger to CEPU-1 or LAMP than the
S-form. This may suggest that these cells express a recep-
tor which binds to the membraneproximal domain of neu-
rotractin which is lacking in the S-form. However, this may
be argued against since the membraneproximal domains
of IgLON members are least conserved in evolution (Pi-
menta et al., 1996a; Brümmendorf et al., 1997) and ligand
or receptor binding sites are frequently located in NH2-
terminal regions of cell adhesion receptors (Brümmendorf
and Rathjen, 1996). Thus, it is also possible that the recep-
tor binding site of neurotractin is located in the amino-
proximal domains but may be sterically inaccessible in the
S-form Fc fusion protein.
In addition to the membrane-bound L- and S-forms, sol-
uble variants of neurotractin may also exist. The immuno-
histochemical analyses show that there are two aspects of
neurotractin expression: First, a prominent labeling of
axon tracts (Fig. 3) and second, for instance in the cerebel-
lum, a weak and diffuse staining (data not shown) which
can be confirmed in Western blot analyses (Fig. 2 C) and
in situ hybridizations (Fig. 4 C). One explanation for the
diffuse staining may be that neurotractin is released from
the cell membrane by an endogenous phospholipase as it
has also been described for axonin-1 (Lierheimer et al.,
1997), another neurite outgrowth–related IgSF member
(Sonderegger, 1997). In the case of axonin-1, the soluble
form may act as a competitive inhibitor of neurite fascicu-
lation (Stoeckli et al., 1991). For neurotractin-L, this ques-
tion will be addressed in future investigations.
Western blot analyses of different brain regions showed
that neurotractin is expressed in retina, telencephalon, tec-
tum, cerebellum, and diencephalon. Furthermore, analysis
of different developmental stages revealed that expression
is increasing in all regions during development (Fig. 2 C).
Upregulation in development has also been observed for
other IgLON molecules, for instance LAMP (Brümmen-
dorf et al., 1997; Hancox et al., 1997) or CEPU-1 (Spalt-
mann and Brümmendorf, 1996), and suggests that these
molecules may also have a function in the mature brain.
Consistently, LAMP has also been found in the adult brain
of human (Pimenta et al., 1996a), rat (Reinoso et al.,
1996), and chick (Hancox et al., 1992). Furthermore, neu-
rotrimin and OBCAM have been detected in postnatal
day 20 rat brain (Struyk et al., 1995). Functions of neu-
rotractin in the adult brain are unknown at present but
may include phenomena which are similar to those in the
developing brain, for instance functions related to neu-
ronal remodelling and plasticity.
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